[1]
Wolter, P. and Schöffski, P. 2010. Targeted therapies in the treatment of GIST: Adverse events and maximising the benefits of sunitinib through proactive therapy management. Acta Oncologica. 49, 1 (Jan. 2010), 13–23. DOI:https://doi.org/10.3109/02841860903287205.